01/05/2020 |
NeuroVive Pharmaceutical AB |
Magnus Hansson |
Chief Medical Officer |
|
Subscription |
NeuroVive Pharmaceutical BTA |
BTA |
SE0014262408 |
29/04/2020 |
126,199 |
Quantity |
0.80 |
SEK |
|
Notification
|
30/04/2020 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Subscription |
Neurovive Pharm BTA |
BTA |
SE0014262408 |
29/04/2020 |
200,149 |
Quantity |
0.80 |
SEK |
|
Notification
|
05/09/2019 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Disposal |
NeuroVive Pharmaceutical AB |
Share |
SE0002575340 |
02/09/2019 |
21,382 |
Quantity |
1.66 |
SEK |
|
Notification
|
05/09/2019 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Acquisition |
NeuroVive Pharmaceutical AB |
Share |
SE0002575340 |
03/09/2019 |
21,382 |
Quantity |
1.60 |
SEK |
|
Notification
|
17/02/2019 |
NeuroVive Pharmaceutical AB |
Catharina Janzon Johansson |
Ekonomi/finanschef |
|
Subscription |
NeuroVive Pharmaceutical AB BTA |
BTA |
SE0012167708 |
15/02/2019 |
25,000 |
Quantity |
1.35 |
SEK |
|
Notification
|
11/02/2019 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Subscription |
NeuroVive Pharmaceutical AB BTA |
BTA |
SE0005620341 |
06/02/2019 |
200,149 |
Quantity |
1.35 |
SEK |
History |
Notification
|
11/02/2019 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Acquisition |
NeuroVive Pharmaceutical AB BTA |
BTA |
SE0005620341 |
06/02/2019 |
200,149 |
Quantity |
1.35 |
SEK |
Revised |
Notification
|
09/02/2019 |
NeuroVive Pharmaceutical AB |
Magnus Hansson |
Chief Medical Officer |
|
Subscription |
NeuroVive Pharmaceutical AB BTA |
BTA |
SE0005620341 |
06/02/2019 |
206,673 |
Quantity |
1.35 |
SEK |
|
Notification
|
28/12/2018 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Acquisition |
NeuroVive Pharmaceutical AB |
Share |
SE0002575340 |
21/12/2018 |
44,901 |
Quantity |
1.32 |
SEK |
|
Notification
|
28/12/2018 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Acquisition |
NeuroVive Pharmaceutical AB |
Share |
SE0002575340 |
27/12/2018 |
73,000 |
Quantity |
1.30 |
SEK |
|
Notification
|